Case Number:

IPR2022-00722

Case Type:

IPR

Status:

Final Written Decision - Appealed

Petitioner:

Mylan Pharmaceuticals Inc. et al.

1. Filed: March 21, 2022 00:00

   Coverage

   1. January 28, 2026

      After Fed. Circ. Remand, PTAB Again Backs Bausch Patent

      The Patent Trial and Appeal Board has found again that MSN Laboratories failed to show that a drug patent owned by Bausch Health Ireland Ltd. was invalid, after the Federal Circuit told the board to take another look last year.

   ---

   Stay ahead of the curve

   In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

   
   

   • Search PTAB cases and full-text documents.
   • Download filings with the U.S. Patent & Trademark Office’s Patent Trial & Appeal Board.
   • Set up alerts on new cases, follow ongoing cases, track new decisions and so much more!

   TRY LAW360 FREE FOR SEVEN DAYS

   View the PTAB case documents

   Already a subscriber? Click here to login